T cell receptor gamma variable 4 (TRGV4)

T cell receptor gamma variable 4 (TRGV4) is a variable gene segment encoding the V region of the gamma chain in the γδ T cell receptor complex, a subset of receptors found on γδ T cells. Unlike the more common αβ T cells, γδ T cells use γδ TCRs (incorporating variable regions such as TRGV4) to recognize a diverse range of antigens, many of which are not peptide-based and can be presented by non-classical MHC-like molecules. TRGV4 contributes specificity to the antigen recognition site of the γ chain, participating in somatic V(D)J recombination to generate immune diversity. Upon ligand engagement, γδ TCRs (with TRGV4) activate T cells via phosphorylation cascades, ultimately mediating rapid immune responses to infection and tissue damage[1][3][4][6]. This receptor complex is a promising area for immunotherapy, particularly in cancer and infectious diseases, but specific drugs targeting TRGV4 are not currently described. Note: TRGV4 is a human gene (HGNC: 12289, NCBI Gene: 6977, Ensembl: ENSG00000211698), with close paralogs such as TRGV2. In mice, a similarly named segment exists but is not the human TRGV4[5][9]. There are no major nomenclature errors, but direct drug interaction studies for TRGV4 itself are limited, as most therapeutic strategies target the entire γδ TCR complex[6].

Other names

TRGV4TCRGV4V1S4T-cell receptor, gamma, variable region V4

For immunotherapies aiming to activate γδ T cells, mechanisms involve harnessing T cell receptor signaling (via TCR–CD3 complex): - Antigen engagement triggers phosphorylation of immunoreceptor tyrosine-based activation motifs (ITAMs) in CD3 chains, leading to signaling cascades that result in T cell activation, proliferation, and effector functions[1][3][6].